ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $115 | -35.0% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $177 | +9.9% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $161 | – | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -80.0% | 500 | -86.7% | 0.00% | – |
| Q3 2020 | $5,000 | – | 3,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,596,680 | $16,725,000 | 2.33% |
| Artal Group S.A. | 150,000 | $698,000 | 0.01% |
| Destination Wealth Management | 29,656 | $138,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $674,000 | 0.01% |
| IHT Wealth Management, LLC | 563 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 695 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 44,048 | $205,000 | 0.00% |
| Vantage Investment Advisors, LLC | 25 | $0 | 0.00% |
| UBS Group AG | 5,204 | $24,000 | 0.00% |
| Legal & General Group Plc | 384 | $2,000 | 0.00% |